The Latest Breaking News on Pharma

Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with President Donald Trump's administration

Tory peer Michelle Mone accused the UK Government of making her and her husband a 'poster couple for the PPE scandal' ...

The U.S. pharmaceutical industry is at the center of a policy maelstrom. President Donald Trump on Sep 25, put a 100% tariff on imported branded and patented medicines starting from Oct 1 with threats that tariffs might go up to as much as 250% in future. The instant market impact…

Genmab A/S (NASDAQ: GMAB) on Monday agreed to acquire Merus N.V. (NASDAQ: MRUS) with its late-stage asset petosemtamab, which is in Phase 3 development, for $97 per share in an all-cash transaction representing a transaction value of approximately $8 billion.

Four biotechnology stocks have surged into the top 10th percentile for momentum ranking, demonstrating remarkable week-on-week technical strength and strong price action.

RFK Jr is conducting a review of mifepristone, citing a deeply flawed study. The move could be devastating for women

The drug and vaccine maker is a £60bn firm – one of the biggest in the UK

British pharmaceutical giant GSK on Monday said longtime chief executive Emma Walmsley will be replaced by its chief commercial officer in January, as the company navigates US tariffs on the sector.

UK’s biggest drugmaker will put its US shares on a par with its London-based stock but says HQ will stay in Cambridge